Agile, Launch-Ready, and Commercially Transformed — Without the Chaos.
We help pharma and biotech leaders modernize marketing, accelerate MLR, and turn launch strategy into predictable commercial execution — led by a senior practitioner who has actually run the P&L.
30+ YEARS IN PHARMA AND HEALTHCARE · EX-MERCK (DIRECTOR, ONCOLOGY), PFIZER, ZOETIS, ALCON · MSc DIGITAL TRANSFORMATION + MBA · ACTIVE CONSULTING AND TEACHING AT COLLÈGE LASALLE, MCGILL, SENECA, WATERLOO
Three problems we solve.
The operating-model bottlenecks holding back your launch, your MLR, and your commercial execution.
The MLR SPRINT Model™
A proprietary operating model for pharma approvals.
Most agile implementations break in pharma because they ignore MLR. Ours doesn’t. The MLR SPRINT Model™ integrates Design Thinking, Systems Thinking, and Agile into a single operating model that makes compliance part of every sprint — not an obstacle at the end of one.
A clear, four-stage engagement.
Designed so you always know what you’re buying.
What changes when you install an agile, MLR-integrated operating model.
Cited industry results. Replicated in real engagements.
57%
Reduction in MLR cycle time
Valuebound, 2024
75%
First-pass approval rate
Veeva Systems, 2024
90 days
Brand strategy cycle
Down from 2+ years · McKinsey, 2020
2–3×
Faster content-to-market with AI pre-screening
Pharmaphorum, 2024
Tools we’ve built.
Every engagement produces reusable IP. Here’s a selection.
If you’re a pharma or biotech leader wondering whether your operating model is the thing holding your launch back — let’s talk.
Thirty minutes. No deck. No pitch. I’ll ask you about your cycle times, your team’s rhythm, and one specific initiative you’re trying to land. If there’s a fit, we’ll discuss what the first six weeks could look like. If there isn’t, you’ll leave with a crisper picture of the bottleneck.






